# RANOLAZINE
> **ANDA210668** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2023-09-27
## Drug
- **FDA Application Number:** ANDA210668
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2023-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210668)
---
*AI Analytics · CC0 1.0*